A Study on The Effect of Multiple Dose Carbamazepine on Single Dose Pharmacokinetics of RO4917838 in Healthy Volunteers
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This open-label, fixed sequence, two-period study will assess the effect of multiple dose
carbamazepine on the single dose pharmacokinetics of RO4917838. Subjects will receive a
single oral dose of RO4917838 on Day 1 of the 12-day study period 1 and, after a washout of
3-6 weeks, in study period 2 carbamazepine orally daily on Days 1-24 with a single oral dose
of RO4917838 on Day 16.